Provides for coverage of screenings for elevated lead levels

Bill A 7953 mandates that screenings for elevated lead levels, when covered by an insurance policy, will not be subject to annual deductibles or coinsurance. This means individuals would not incur additional out-of-pocket costs, such as a deductible or coinsurance, for these specific screenings. The bill also amends social services law to ensure that screening and blood tests for elevated lead levels in children are a covered service. "Elevated lead levels" are defined by referencing an existing public health law.